Host: David T. Rubin, MD
Guest: Christina Ha, MD, FACG, AGAF
Here to review new and emerging biomarkers that offer the potential to personalize therapy in ulcerative colitis are Drs. David Rubin and Christina Ha. Together, they’ll discuss the efficacy and safety of newer therapies and mechanisms of action in comparison to currently available treatment options.